Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
News Medical on MSN
Leukemia That Starts Before Birth Is More Aggressive
A Mount Sinai team showed that the same leukemia mutation behaves differently depending on when it arises during development.
In cooperation with universities, the Center of Estonian Rural Research and Knowledge (METK) is leading a project aimed at ...
Biotech startup CrisprBits uses CRISPR-based techniques to change the shape of diagnostics by decoding genetic sequencing ...
Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
TipRanks on MSN
CRISPR Therapeutics AG: Stock surge amid challenges
Crispr Therapeutics AG ( ($CRSP) ) has risen by 9.03%. Read on to learn why. Crispr Therapeutics AG has seen its stock price rise by 9.03% over ...
Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback